Lomedeucitinib

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C18H20N6O4S
Molecular Weight	419.473
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[2H]C([2H])([2H])NC(=O)C1=C(NC2=C(C=CC=N2)S(C)(=O)=O)C=C(NC(=O)[C@@H]3CC34CC4)N=N1

InChI

InChIKey=VWIVBQZLVAGLMH-ASGODXDTSA-N

InChI=1S/C18H20N6O4S/c1-19-17(26)14-11(21-15-12(29(2,27)28)4-3-7-20-15)8-13(23-24-14)22-16(25)10-9-18(10)5-6-18/h3-4,7-8,10H,5-6,9H2,1-2H3,(H,19,26)(H2,20,21,22,23,25)/t10-/m0/s1/i1D3

HIDE SMILES / InChI

Approval Year

Name

Type

Language

Lomedeucitinib

Official Name

English

BMS-986322

Code

English

N-[(<sup>2</sup>H<sub>3</sub>)methyl]-4-{[3-(methanesulfonyl)pyridin-2-yl]amino}-6-(spiro[2.2]pentan-1-carboxamido)pyridazine-3-carboxamide

Systematic Name

English

LOMEDEUCITINIB [USAN]

Common Name

English

3-Pyridazinecarboxamide, N-(methyl-d3)-4-[[3-(methylsulfonyl)-2-pyridinyl]amino]-6-[[(1R)-spiro[2.2]pent-1-ylcarbonyl]amino]-

Systematic Name

English

BMS-986322-01

Code

English

Code System Code Type Description

FDA UNII

EYQ7KA55XA

Created by admin on Sat Dec 16 15:04:58 GMT 2023 , Edited by admin on Sat Dec 16 15:04:58 GMT 2023

PRIMARY

PUBCHEM

138620496

Created by admin on Sat Dec 16 15:04:58 GMT 2023 , Edited by admin on Sat Dec 16 15:04:58 GMT 2023

PRIMARY

INN

12982

Created by admin on Sat Dec 16 15:04:58 GMT 2023 , Edited by admin on Sat Dec 16 15:04:58 GMT 2023

PRIMARY

USAN

LM-33

Created by admin on Sat Dec 16 15:04:58 GMT 2023 , Edited by admin on Sat Dec 16 15:04:58 GMT 2023

PRIMARY

ACTIVE MOIETY


					EYQ7KA55XA

Lomedeucitinib